Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
Cuiqing Ma, Shan Su, Jiachao Wang, et al.
Microbes and Infection (2020) Vol. 22, Iss. 6-7, pp. 245-253
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
Liangwei Duan, Qianqian Zheng, Hongxia Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 403
COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
John P. Moore, Per Johan Klasse
Journal of Virology (2020) Vol. 94, Iss. 17
Open Access | Times Cited: 92
The COVID-19 Vaccines: Recent Development, Challenges and Prospects
Yuxin Yan, Yoongxin Pang, Zhuoyi Lyu, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 349-349
Open Access | Times Cited: 79
Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19
Bin Zheng, Wenchang Peng, Mingming Guo, et al.
Chemical Engineering Journal (2021) Vol. 418, pp. 129392-129392
Open Access | Times Cited: 67
Advances in the design and development of SARS-CoV-2 vaccines
Xue‐Liang Peng, Ji‐Si‐Yu Cheng, Hai‐Lun Gong, et al.
Military Medical Research (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 66
Sunlight‐Sensitive Plasmonic Nanostructured Composites as Photocatalytic Coating with Antibacterial Properties
Laura Marín‐Caba, Gustavo Bodelón, Yoel Negrín‐Montecelo, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 46
Open Access | Times Cited: 56
New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals
Jun Chen, Hongzhou Lu
BioScience Trends (2021) Vol. 15, Iss. 2, pp. 126-128
Open Access | Times Cited: 55
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
Titus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 545-545
Open Access | Times Cited: 21
The Emergency Response Capacity of Plant-Based Biopharmaceutical Manufacturing-What It Is and What It Could Be
Daniel Tusé, Somen Nandi, Karen A. McDonald, et al.
Frontiers in Plant Science (2020) Vol. 11
Open Access | Times Cited: 66
Plant-based vaccines and antibodies to combat COVID-19: current status and prospects
Kuldeep Dhama, Senthilkumar Natesan, Mohd. Iqbal Yatoo, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 12, pp. 2913-2920
Open Access | Times Cited: 55
Evaluation of Neutralizing Antibodies Against Highly Pathogenic Coronaviruses: A Detailed Protocol for a Rapid Evaluation of Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudovirus-Based Assay
Sarah A. Almahboub, Abdullah Algaissi, Mohamed A. Alfaleh, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 53
Precision therapeutic targets for COVID-19
Zachary A. Krumm, Grace M. Lloyd, Connor Francis, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 53
Oral Immunisation With Non‐GMO Surface Displayed SARS‐CoV‐2 Spike Epitopes on Bacteria‐Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut Microbiome in Mice
Robie Vasquez, Ji Hoon Song, Remilyn M. Mendoza, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access
Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-analysis
Endang Mutiawati, Syahrul Syahrul, Marhami Fahriani, et al.
F1000Research (2020) Vol. 9, pp. 1316-1316
Open Access | Times Cited: 40
Subunit microparticulate vaccine delivery using microneedles trigger significant SARS-spike-specific humoral and cellular responses in a preclinical murine model
Smital Patil, Sharon Vijayanand, Devyani Joshi, et al.
International Journal of Pharmaceutics (2023) Vol. 632, pp. 122583-122583
Open Access | Times Cited: 12
An insight into the epitope-based peptide vaccine design strategy and studies against COVID-19
Murat Topuzoğulları, Tayfun Acar, Pelin Pelit Arayıcı, et al.
TURKISH JOURNAL OF BIOLOGY (2020) Vol. 44, Iss. 3, pp. 215-227
Open Access | Times Cited: 33
Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-analysis
Endang Mutiawati, Syahrul Syahrul, Marhami Fahriani, et al.
F1000Research (2021) Vol. 9, pp. 1316-1316
Open Access | Times Cited: 28
Enhanced antibacterial efficacy through piezo memorial effect of CaTiO3/TiO2 Nano-Composite
Karzan Qurbani, Omid Amiri, Gona M. Othman, et al.
Inorganic Chemistry Communications (2024) Vol. 165, pp. 112470-112470
Closed Access | Times Cited: 3
Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model
Tripti Shrivastava, Balwant Singh, Zaigham Abbas Rizvi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
Bio-mimic particles for the enhanced vaccinations: Lessons learnt from the natural traits and pathogenic invasion
Sihua Wu, Yufei Xia, Yuning Hu, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113871-113871
Open Access | Times Cited: 21
SARS-CoV 2 spike protein S1 subunit as an ideal target for stable vaccines: A bioinformatic study
Nagesha Somakalapalli Narasimhappa, Ramesh B.N., C. Pradeep, et al.
Materials Today Proceedings (2021) Vol. 49, pp. 904-912
Open Access | Times Cited: 20
Emergence of SARS and COVID-19 and preparedness for the next emerging disease X
Ben Hu, Hua Guo, Hao-Rui Si, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 1, pp. 1-18
Closed Access | Times Cited: 2
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-Cov-2 Infection
Titus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, et al.
(2023)
Open Access | Times Cited: 7
The Inhibition of RNA Viruses by Amaryllidaceae Alkaloids: Opportunities for the Development of Broad‐Spectrum Anti‐Coronavirus Drugs
Shen Tan, Martin G. Banwell, Wen‐Cai Ye, et al.
Chemistry - An Asian Journal (2022) Vol. 17, Iss. 4
Closed Access | Times Cited: 10
Zoonotic Origin and Evolution of SARS Coronavirus
Zheng‐Li Shi, Ben Hu, Lin‐Fa Wang
Elsevier eBooks (2024), pp. 841-861
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top